FDA Clarifies Skin Protectant Labeling, Ingredient Combination Options
This article was originally published in The Tan Sheet
Executive Summary
FDA attempts to clarify the active ingredients manufacturers may combine in OTC skin protectant drug products and details corresponding label requirements in draft guidance released Aug. 1